PP18 Effectiveness And Safety Of Long-Acting Agents-Based Dual Therapy In HIV-1/AIDS Patients: A Network Meta-Analysis Of Observational Studies

Daniela Gorski, Bruno Gonçalves Ferreira, Helena Hiemisch Lobo Borba, Fernanda Stumpf Tonin, Roberto Pontarolo · 2025

Read PP18 Effectiveness And Safety Of Long-Acting Agents-Based Dual Therapy In HIV-1/AIDS Patients: A Network Meta-Analysis Of Observational Studies by Daniela Gorski, Bruno Gonçalves Ferreira, Helena Hiemisch Lobo Borba, Fernanda Stumpf Tonin, Roberto Pontarolo (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12768743.txt.

Description

Daniela Gorski and co-authors pool observational evidence on long-acting dual therapy for HIV, where two-drug regimens replace daily handfuls of pills. Daily multi-pill schedules strain adherence, and long-acting injections promise relief. The open question is whether the simpler plans hold the virus down as safely over time.

Their 2025 network meta-analysis gathers longitudinal studies of dual regimens built on long-acting agents such as cabotegravir, rilpivirine, and lenacapavir. Virologic failure is compared across the network, while dropouts from side effects are pooled head by head. The synthesis is meant to rank the options on real-world evidence, giving clinics a map of which pairs keep working outside the polish of trials.

Catalog record

CREATORDaniela Gorski, Bruno Gonçalves Ferreira, Helena Hiemisch Lobo Borba, Fernanda Stumpf Tonin, Roberto Pontarolo
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE3 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12768743

Browse the full library · About the Tower of Babel